The Effect of Atorvastatin Intensity, Obesity, Gender, and Age upon New-onset Type 2 Diabetes Incidence among Libyan Coronary Heart Disease Patients
International Journal of Diabetes Management · 2024
DOI: 10.61797/ijdm.v3i1.314 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Diabetes Management, 2024. Verfasst von Younis MYG und 2 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background: Atorvastatin is one of the statins family of lipid-lowering drugs. Statin has been linked to protective actions against cardiovascular disease; however, the use of statin has been linked to an increased risk of diabetes. Aim of the study: To assess the prevalence of diabetes following the use of Atorvastatin and also to evaluate the effect of the statin intensity, BMI, age, and gender upon the glycemic control and incidence of diabetes. Material and methods: 200 CHD patients divided into 2 groups. The atorvastatin group (using Atorvastatin (40 or 80 mg/day) for
Zitieren
APA
MYG, Y., Abdulla, S. A., & Mohamed, T. L. (2024). The Effect of Atorvastatin Intensity, Obesity, Gender, and Age upon New-onset Type 2 Diabetes Incidence among Libyan Coronary Heart Disease Patients. International Journal of Diabetes Management. https://doi.org/10.61797/ijdm.v3i1.314
Vancouver
MYG Y, Abdulla SA, Mohamed TL. The Effect of Atorvastatin Intensity, Obesity, Gender, and Age upon New-onset Type 2 Diabetes Incidence among Libyan Coronary Heart Disease Patients. International Journal of Diabetes Management. 2024. doi:10.61797/ijdm.v3i1.314
BibTeX
@article{MYG2024,
author = {MYG, Younis and Abdulla, Sara A and Mohamed, Tarek Lamlom},
title = {The Effect of Atorvastatin Intensity, Obesity, Gender, and Age upon New-onset Type 2 Diabetes Incidence among Libyan Coronary Heart Disease Patients},
journal = {International Journal of Diabetes Management},
year = {2024},
doi = {10.61797/ijdm.v3i1.314}
}
EUVIMED